Transactions
11
Insider / STERIS plc
Zangerle John Adam
Sr. VP, Gen Counsel, and Sec. at STERIS plc
- Company
- STERIS plc
- Ticker
- STE
- First filing on record
- October 3, 2025
- Latest trade on record
- June 15, 2026
- SEC filings
- EDGAR ↗
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec. at STERIS plc, has disclosed 11 transactions in STE since October 3, 2025: 0 purchases (0 open-market buys) and 7 sales, worth about $5.5M at the reported prices. The latest was filed June 16, 2026, 1 day after the trade.
Open-market buys
0
Sales
7
Avg. disclosure lag
2.1d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Zangerle John Adam made no purchases and 6 sales worth $4.5M, plus 4 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Zangerle John Adam has traded 1 stock on record; the largest by dollars is STE.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 7 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| F | Shares withheld for tax | 5 | 1,441 | $214K |
| A | Grant or award | 2 | 19,559 | — |
| M | Option exercise or conversion | 2 | 30,000 | $1.0M |
| S | Open-market sale | 2 | 16,419 | $4.3M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 7 | 0 | 5 · $511K |
| 2025 | 4 | 0 | 2 · $4.0M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| STE | Sell S | June 15, 2026 | June 16, 2026 | 1d | 1,419 | $209 | $297K | 10b5-1 plan | Form 4 ↗ | |
| STE | Sell F | June 4, 2026 | June 8, 2026 | 4d | 401 | $212 | $85K | Form 4 ↗ | ||
| STE | Sell F | June 3, 2026 | June 5, 2026 | 2d | 365 | $210 | $77K | Form 4 ↗ | ||
| STE | Other A | June 2, 2026 | June 4, 2026 | 2d | 15,200 | — | — | derivative | Form 4 ↗ | |
| STE | Sell F | June 2, 2026 | June 4, 2026 | 2d | 247 | $210 | $52K | Form 4 ↗ | ||
| STE | Other A | June 2, 2026 | June 4, 2026 | 2d | 4,359 | — | — | Form 4 ↗ | ||
| STE | Sell F | June 1, 2026 | June 3, 2026 | 2d | 337 | — | — | Form 4 ↗ | ||
| STE | Option / conversion M | November 11, 2025 | November 13, 2025 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| STE | Sell S | November 11, 2025 | November 13, 2025 | 2d | 15,000 | $265 | $4.0M | Form 4 ↗ | ||
| STE | Option / conversion M | November 11, 2025 | November 13, 2025 | 2d | 15,000 | $70 | $1.0M | Form 4 ↗ | ||
| STE | Sell F | October 1, 2025 | October 3, 2025 | 2d | 91 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 16, 2026 | Form 4 | 0001628280-26-043561 | 1 | published | EDGAR ↗ |
| June 8, 2026 | Form 4 | 0001628280-26-041640 | 1 | published | EDGAR ↗ |
| June 5, 2026 | Form 4 | 0001628280-26-041284 | 1 | published | EDGAR ↗ |
| June 4, 2026 | Form 4 | 0001628280-26-040848 | 3 | published | EDGAR ↗ |
| June 3, 2026 | Form 4 | 0001628280-26-040445 | 1 | published | EDGAR ↗ |
| November 13, 2025 | Form 4 | 0001628280-25-052076 | 3 | published | EDGAR ↗ |
| October 3, 2025 | Form 4 | 0001628280-25-044120 | 1 | published | EDGAR ↗ |
Other insiders at STERIS plc
- Sohi Mohsen Director 14 rows
- Madsen Julia Sr. VP and GM, Life Sciences 13 rows
- Tamaro Renato V.P. & Corporate Treasurer 12 rows
- Burton Karen L Sr. Vice Pres., CFO 10 rows
- Carestio Daniel A President and CEO 10 rows
- Fraser Mary Clare SVP & Chief HRO 7 rows
- Kohler Kenneth E SVP & GM, AST 6 rows
- FELDMANN CYNTHIA L Director 5 rows
- Majors Cary L SVP and President, Healthcare 5 rows
- McGowan Lindsey VP, Chf. Comp. & Quality Offc. 5 rows
Everyone on file, with contracts and lobbying under the company's name: STERIS plc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 7 | 11 | October 3, 2025 | June 16, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.